Enterome

Paris, France · Founded 2008 · Privately Held (backing)

Developer of pharmaceuticals and diagnostic tests designed for developing off-the-shelf, transformational cancer treatments targeting all tumor types. Enterome is based in Paris, France and was founded in 2008. Its last reported valuation was $217 million in Jul 2022. It has raised $292 million.

Last reported valuation

$217.0M

Oct 2026

Priced at

—

Total raised

$292.3M

Last round

—

How much has Enterome raised?

$292.3Macross 0 recorded rounds

Free account

More of Enterome with a free account

·The complete investor list: 18 names
·Watch Enterome: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Enterome investors

18 investors are on record for Enterome, including Omnes Capital, Bristol-Myers Squibb, Primo Capital (Milano) and Takeda Ventures.

For fundraisers

Raising for a company like Enterome?

18 investors have backed Enterome.

See all 18 investors →

Frequently asked about Enterome

How much has Enterome raised?: Enterome has raised $292.3M in total across 0 recorded funding rounds.